Kayarash is a Senior Associate at Cure Ventures, where he focuses on company creation efforts. His work at Cure is driven by a mission to develop transformative medicines through a culture rooted in scientific rigor, creativity, and patient-centric innovation.
Kayarash earned his PhD at the Johns Hopkins University School of Medicine as a National Science Foundation Graduate Fellow. He worked under the mentorship of Nobel Laureate Dr. Carol Greider to investigate the molecular mechanisms of telomere biology and developed Nanopore telomere profiling for diagnosing telomere diseases in patients. He discovered that specific chromosomes have the shortest telomeres across humans. Prior to Cure, Kayarash was an associate at Third Rock Ventures where he was involved in creating new biotech companies by working with leading academics. He was part of the founding team of a NewCo and helped lead a drug discovery campaign and clinical development planning for two lead programs.